Research and experimental development on natural sciences and engineering
ALDEN CANCER THERAPY AS
Operating profit
NOK −1.9m
Equity
NOK −2.8m
Incorporated
2013
Share capital
NOK 47,000
Roles
Daglig lederKarl Henning Kalland
Regnskapsfører
Revisor
Styrets lederAnders Haugland
StyremedlemKarl Henning Kalland
StyremedlemAnne Margrete Øyan
StyremedlemStener Kvinnsland
StyremedlemBjørn Tore Gjertsen
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| YZ HOLDING AS | 58.9% | 66.000000 | 2025 |
| VESTLANDETS INNOVASJONSSELSKAP AS | 30.4% | 34.000000 | 2025 |
| STENER KVINNSLAND | 3.6% | 4.000000 | 2025 |
| OCEANVIEW VENTURE CAPITAL AS | 3.6% | 4.000000 | 2025 |
| MARCK INVEST AS | 3.6% | 4.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.